Pharmaceuticals Archives - Page 43 of 49

EC approves Novartis’ Mayzent to treat SPMS in adults

21 Jan 20

Mayzent selectively binds to S1P1 and S1P5 receptors to prevent lymphocytes from leaving the lymph nodes and entering…

20 Jan 20

BBT-176 has demonstrated strong anti-tumour efficacy, and enhanced efficacy when used along with anti-EGFR antibodies in the pre-clinical…

17 Jan 20

The FDA approval is based on the results of SUSTAIN 6 cardiovascular outcomes trial (CVOT) which showed positive…

16 Jan 20

Dovato is a once-daily, single-pill, 2-drug regimen that combines integrase inhibitor (INI) dolutegravir, and the nucleoside reverse transcriptase…

16 Jan 20

Janssen has secured the European Commission approval of SPRAVATO nasal spray for treatment-resistant major depressive disorder (TRD), in…

13 Jan 20

Fostemsavir was submitted for the US FDA new drug application (NDA), and was granted FDA fast track and…

10 Jan 20

AYVAKIT marks the first precision therapy to be approved by the FDA to treat a genomically defined population…

09 Jan 20

FDA has approved KEYTRUDA based on data from KEYNOTE-057, a multicentre, open-label, single-arm trial, involving 96 patients

20 Dec 19

Ervebo is now the first FDA-approved vaccine for Ebola and is indicated to be used in people aged…